Giuseppe
Emeritus
[Source: Eurosurveillance, full text: (LINK). Abstract, edited.]
Eurosurveillance, Volume 16, Issue 48, 01 December 2011
Rapid communications
Trends in HIV and hepatitis C virus infections among injecting drug users in Europe, 2005 to 2010
L Wiessing (
)<SUP>1</SUP>, G Likatavicius<SUP>2</SUP>, D Hedrich<SUP>1</SUP>, B Guarita<SUP>1</SUP>, M J van de Laar , J Vicente<SUP>1</SUP>
Citation style for this article: Wiessing L, Likatavicius G, Hedrich D, Guarita B, van de Laar MJ, Vicente J. Trends in HIV and hepatitis C virus infections among injecting drug users in Europe, 2005 to 2010. Euro Surveill. 2011;16(48)
ii=20031. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20031
Date of submission: 29 November 2011 <HR>Data on newly diagnosed HIV infections and HIV prevalence in 2005 to 2010 suggest falling infection rates in injecting drug users (IDUs) in the European Union (EU). However, recent increases in HIV and hepatitis C virus (HCV) infection rates in IDUs suggest increasing injecting risks in some countries. The coverage of effective prevention measures has increased, but is still low in several countries. Overall the data suggest a continued risk of new outbreaks of HIV infection among IDUs.
- ------
Eurosurveillance, Volume 16, Issue 48, 01 December 2011
Rapid communications
Trends in HIV and hepatitis C virus infections among injecting drug users in Europe, 2005 to 2010
L Wiessing (
- European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal
- European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
Citation style for this article: Wiessing L, Likatavicius G, Hedrich D, Guarita B, van de Laar MJ, Vicente J. Trends in HIV and hepatitis C virus infections among injecting drug users in Europe, 2005 to 2010. Euro Surveill. 2011;16(48)
ii=20031. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20031 Date of submission: 29 November 2011 <HR>Data on newly diagnosed HIV infections and HIV prevalence in 2005 to 2010 suggest falling infection rates in injecting drug users (IDUs) in the European Union (EU). However, recent increases in HIV and hepatitis C virus (HCV) infection rates in IDUs suggest increasing injecting risks in some countries. The coverage of effective prevention measures has increased, but is still low in several countries. Overall the data suggest a continued risk of new outbreaks of HIV infection among IDUs.